Clinical Trials Logo

Clinical Trial Details — Status: Not yet recruiting

Administrative data

NCT number NCT06407076
Other study ID # FisUCI
Secondary ID
Status Not yet recruiting
Phase
First received
Last updated
Start date May 9, 2024
Est. completion date July 1, 2024

Study information

Verified date May 2024
Source University of Oviedo
Contact Rubén Cuesta Barriuso, PhD
Phone 607547274
Email cuestaruben@uniovi.es
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

Background. A stay in the Intensive Care Unit can cause long-term problems and physiological changes at the neuromuscular and respiratory levels in critically ill patients. Early physiotherapy in these patients is safe and feasible to avoid or reduce the adverse musculoskeletal and respiratory effects of the stay in this hospital unit. Objective. To identify the strengths and barriers of Physiotherapy in an Intensive Care Unit, according to the vision of different Health Science professionals. Method. Qualitative observational study using individual interviews and focus groups. 18 people (6 doctors, 6 nurses and 6 physiotherapists) will be included in the study. The 18 health professionals will participate in personal interviews and focus groups (3 focus groups with 6 participants each). Participants will be recruited from the Intensive Care Unit of the Hospital Universitario Central de Asturias. Data will be analysed using the thematic analysis approach according to Braun and Clarke's method. We will use face-to-face interviews and focus groups to collect data and analyse them through thematic analysis. Purposive sampling will be used to recruit our participants. We will continue to recruit participants, if necessary, until saturation of data from the thematic analysis is reached. Expected outcomes. To assess the knowledge, perceptions and expectations of the healthcare staff in the Intensive Care Unit regarding Physiotherapy in the management of patients admitted to this Unit. To identify the strengths of Physiotherapy in the management of these patients.


Recruitment information / eligibility

Status Not yet recruiting
Enrollment 18
Est. completion date July 1, 2024
Est. primary completion date May 15, 2024
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 30 Years to 65 Years
Eligibility Inclusion Criteria: - Professionals from the Intensive Care Unit of the Hospital Universitario Central de Asturias. - With clinical experience of at least 2 years. - Currently working or having worked in coordination with physiotherapists in the Intensive Care Unit. Exclusion Criteria: - Professionals who are unfamiliar with the usual physiotherapy therapy in an Intensive Care Unit. - Resident interns in their first year of training.

Study Design


Related Conditions & MeSH terms


Intervention

Other:
Interviews
Following the design of the questionnaire, using open-ended questions based on the availability, accessibility, acceptability and quality (AAAQ) framework, qualitative semi-structured personal interviews were used to collect the data. In this way it was possible to collect information in a more detailed way. The subjects included in the study had to answer the questions posed by the main researcher, responding with open or closed answers, through a questionnaire created for this purpose.

Locations

Country Name City State
Spain University of Oviedo Oviedo Asturias

Sponsors (1)

Lead Sponsor Collaborator
University of Oviedo

Country where clinical trial is conducted

Spain, 

Outcome

Type Measure Description Time frame Safety issue
Primary Assess the knowledge on Physiotherapy in the Intensive Care Unit Through open questions focused on the knowledge of physiotherapy in the hospital setting of the Intensive Care Unit: "Are you familiar with the presence of physiotherapists in ICUs?", "Have you previously worked in an ICU that includes physiotherapists?", "Once a patient is admitted to the ICU, when should the physiotherapy intervention start? And when does it actually start?", "What do you think are and should be the functions of physiotherapists in the ICU?", "What do you think are and should be the functions of physiotherapists in the ICU? Screening visit
Primary Assess the benefits on Physiotherapy in the Intensive Care Unit Through open questions focused on the benefits of physiotherapy in the hospital environment of the Intensive Care Unit: "What do you think are the benefits for patients of having physiotherapists in the ICU?", "From the point of view of the work of the physiotherapist, what benefits do you consider most important for the patients admitted to the ICU?", "From the point of view of the work of the physiotherapist, what benefits do you consider most important to facilitate multidisciplinary work in the ICU?" Screening visit
Primary Assess the collaboration between healthcare professionals in the Intensive Care Unit Through open questions focused on the collaboration between healthcare professionals in the Intensive Care Unit: "Have you experienced any challenges in the collaboration between the professionals involved in ICU care in relation to physiotherapy?", "How do you think multidisciplinary collaboration between healthcare professionals in the ICU and the physiotherapists working in the ICU could be improved? Screening visit
Primary Assess the needs and recommendations of Physiotherapy in the Intensive Care Unit. Through open questions focused on the needs and recommendations of Physiotherapy in the Intensive Care Unit: "What additional resources or support do you consider necessary to optimise the presence of physiotherapists in the ICU?", "Do you have any specific recommendations to improve the integration of physiotherapists in the care of patients admitted to the ICU? Screening visit
See also
  Status Clinical Trial Phase
Active, not recruiting NCT04769349 - Effectiveness of Supportive Housing on COVID-19 Related Outcomes for People Experiencing Homelessness
Completed NCT01765595 - Clinical and Economic Impact of an Electronic Medical Record Interfaced Decision Support System for Minimizing Severe Drug-Drug Interactions N/A
Completed NCT01765621 - Clinical and Economic Impact of an Electronic Medical Record Interfaced Decision Support System Reinforced With Patient Specific Pharmacogenetic Data for Minimizing Severe Drug-Drug Interactions N/A